SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Burnett AK. Tailoring the treatment of acute myeloid leukemia. Curr Opin Hematol 1999;6:247253.
  • 2
    Heim S, Mitelman F. Cancer cytogenetics. 2nd edition. New York: Wiley-Liss; 1995.
  • 3
    Bennett JM, Catovsky D, Daniel MT, Flandrin G, Dalton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985;103:626629.
  • 4
    Arthur DC, Bloomfield CD. Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. Blood 1983;61:994998.
  • 5
    Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD. Association of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic–clinicopathological association. N Engl J Med 1983;309:630636.
  • 6
    Liu PP, Hajra C, Wijmenga C, Collins FS. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995;85:22892302.
  • 7
    Mitelman F, Johansson B, Mertens F (editors). Mitelman Database of Chromosome Aberrations in Cancer 2001. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
  • 8
    Adriaansen HJ, te Boekhorst PA, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJ. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993;81:30433051.
  • 9
    Paietta E, Wiernik PH, Andersen J, Bennett J, Yunis J. Acute myeloid leukemia M4 with inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993;82:2595.
  • 10
    Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol 1998;109:211220.
  • 11
    Holmes R, Keating MJ, Cork A, Broach Y, Trujillo J, Dalton WT Jr, McCredie KB, Freireich EJ. A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood 1985;65:10711078.
  • 12
    Haferlach T, Gassmann W, Loffler H, Jurgensen C, Noak J, Ludwig WD, Thiel E, Haase D, Fonatsch C, Becher R, et al. Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group. Ann Hematol 1993;66:165170.
  • 13
    Larson RA, Williams SF, LeBeau MM, Bitter MA, Vardiman JW, Rowley JD. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood 1986;68:12421249.
  • 14
    Plantier I, Lai JL, Wattel E, Bauters F, Fenaux P. Inv(16) may be one of the only “favorable” factors in acute myeloid leukemia: a report of 19 cases with prolonged follow-up. Leuk Res 1994;18:885888.
  • 15
    Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pattenati MJ, Tantravahi R, Patil SR, Davey FR, Berg DT, Schiffer CA, Arthur DC, Mayer RJ. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 1998;58:41734179.
  • 16
    Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 Patients entered into the MRC AML 10 Trial. Blood 1998;92:23222333.
  • 17
    Mitterbauer M, Laczika K, Novak M, Mitterbauer G, Hilgarth B, Pirc-Danoewinata H, Schwarzinger I, Haas OA, Fonatsch C, Lechner K, Jaeger U. High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study. Am J Clin Pathol 2000;113:406410.
  • 18
    Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia 1995;9:965971.
  • 19
    MitelmanF (editor). ISCN 1995. An International System for Cytogenetic Nomenclature. Basel: Karger; 1995.
  • 20
    Andreasson P, Johansson B, Arheden K, Billström R, Mitelman F, Höglund M. Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosomes Cancer 1997;19:7783.
  • 21
    Whittaker JA. Acute myeloid leukemia. In: WhittakerJA, HolmesJA, editors. Leukemia and related disorders. 3rd edition. Oxford, England: Blackwell Science; 1998. p 165172.
  • 22
    Greer JP, Baer MR, Kinney MC. Acute myelogenous leukemia. In: LeeGR, FoersterJ, LukensJ, ParaskevasF, GreerJP, RodgersGM, editors. Wintrobe's clinical hematology. 10th edition. Baltimore, MD: Williams & Wilkins; 1999. p 22722320.
  • 23
    Gollard RP, Robbins BA, Piro L, Saven A. Acute myelogenous leukemia presenting with bulky lymphadenopathy. Case report and literature review. Acta Haematol 1996;95:129134.
  • 24
    Sica S, Salutari P, d'Onofrio G, Zini G, Laurenti L, Sora F, Leone G. Bulky lymphadenopathy in acute myeloid leukemia. Ann Hematol 1998;77:6567.
  • 25
    Zapf B, Carpenter RJ, Snyder GG. Ulcerating tumor of tonsil and neck mass as occurrence of acute myelocytic leukemia. Otolaryngol Head Neck Surg 1981;89:560563.
  • 26
    Bisschop MM, Revesz T, Bierings M, van Weerden JF, van Wering ER, Hahlen K, van der Does-van den Berg A. Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia. Leukemia 2001;15:4649.
  • 27
    Johansson B, Billström R, Broberg K, Fioretos T, Nilsson PG, Ahlgren T, Malm C, Samuelsson BO, Mitelman F. Cytogenetic polyclonality in hematologic malignancies. Genes Chromosomes Cancer 1999;24:222229.
  • 28
    Panagopoulos I, Åman P, Johansson B, Malm C, Lenhoff S, Billstrom R, Mitelman F. NRAS mutations are rare in acute myeloid leukemias with t(8;21) or inv(16). Eur J Haematol 1996;56:6871.
  • 29
    Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute non-lymphocytic leukemia. Cancer Genet Cytogenet 1981;4:197214.
  • 30
    Bernard P, Dachary D, Reiffers J, Marit G, Wen Z, Jonveaux P, David B, Lacombe F, Broustet A. Acute nonlymphocytic leukemia with marrow eosinophilia and chromosome 16 abnormality: A report of 18 cases. Leukemia 1989;3:740745.
  • 31
    Monahan BP, Rector JT, Liu PP, Cotelingam JD, Dahut W. Clinical aspects of expression of inversion 16 chromosomal fusion transcript CBFB/MYH11 in acute myelogenous leukemia subtype M1 with abnormal bone marrow eosinophilia. Leukemia 1996;10:16531654.
  • 32
    Costello R, Sainty D, Lecine P, Cusenier A, Mozziconacci MJ, Arnoulet C, Maraninchi D, Gastaut JA, Imbert J, Lafage-Pochitaloff M, Gabert J. Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics. Leukemia 1997;11:644650.